|
|
楼主 |
发表于 2015-1-31 09:55:59
|
显示全部楼层
目录:
: b# H; @& ]+ y- TVirus Infection and Human Cancer: An Overview . . . . . . . . . . . . . . . 1
" P- l& F8 y' J/ X3 d! D2 Y4 jJohn T. Schiller and Douglas R. Lowy5 n9 f0 q, J8 R; N7 W' _. t
Epidemiology of Virus Infection and Human Cancer . . . . . . . . . . . . . 11
3 h, r4 n: G( }" b8 g* t$ zChien-Jen Chen, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee,
4 a/ z+ S1 t. @, T1 l4 LHui-Chi Chen, Yin-Chu Chien and San-Lin You
9 V7 p, ?" e2 jVirus Infection, Inflammation and Prevention of Cancer . . . . . . . . . . 33, H9 C" M* b# M# y) k( f
Norman Woller and Florian Kühnel* v: Z1 l1 i" q
The Oncogenic Role of Hepatitis B Virus . . . . . . . . . . . . . . . . . . . . . . 59
9 @' @+ F" f, n& F Z) }9 B6 gLise Rivière, Aurélie Ducroux and Marie Annick Buendia K5 a2 `* ]$ ^
Prevention of Hepatitis B Virus Infection and Liver Cancer . . . . . . . . 75
" z7 ^) V" H! `; @- xMei-Hwei Chang: V H" q+ e! a, Y1 m4 k
The Oncogenic Role of Hepatitis C Virus. . . . . . . . . . . . . . . . . . . . . . 97
3 k$ [0 J4 [% D- N- T; b+ ?Kazuhiko Koike
% @& ]1 z' z. F% RPrevention of Hepatitis C Virus Infection and Liver Cancer . . . . . . . . 113
! b. I# K' G2 {! z% |E. J. Lim and J. Torresi
i* x0 U- W' i: [- ?The Role of Human Papillomaviruses in Oncogenesis . . . . . . . . . . . . . 135+ u0 x1 s# W% c/ f/ N- `9 R7 l7 {( R
Kristen K. Mighty and Laimonis A. Laimins
2 J( c/ |0 G1 h1 g: D! KControl of HPV Infection and Related Cancer
2 c3 t8 a8 Y& M1 m }+ cThrough Vaccination. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149, W8 f/ H4 q# @0 Z: z6 ]" H
Nam Phuong Tran, Chien-Fu Hung, Richard Roden and T.-C. Wu3 ^, Y# _1 u$ U' D9 u0 n" ]
Prevention and Treatment for Epstein–Barr Virus Infection7 Q$ g% t& M5 V$ W9 H
and Related Cancers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173. K; j& a# T% I' v
Françoise Smets and Etienne M. Sokal, p. | h; B% t8 b
HTLV-1 and Leukemogenesis: Virus–Cell Interactions
$ ^$ o: w* }0 @( `5 y/ ain the Development of Adult T-Cell Leukemia . . . . . . . . . . . . . . . . . . 191
5 x6 [- F7 i5 ^# u8 z( S* BLinda Zane and Kuan-Teh Jeang9 i3 H1 G) s3 K
Prevention of Human T-Cell Lymphotropic Virus Type 1: ~3 h- Z0 \ M3 @+ K0 F# x; X
Infection and Adult T-Cell Leukemia/Lymphoma. . . . . . . . . . . . . . . . 211
- y6 ^2 p/ C3 L# l5 G% N: ^, n; WMakoto Yoshimitsu, Yohann White and Naomichi Arima0 z3 c; F# g3 x9 R
Molecular Biology of Human Herpesvirus 8: Novel Functions _4 n* X4 d! F9 B+ P
and Virus–Host Interactions Implicated in Viral Pathogenesis
( s: N0 M7 z# b3 D# `9 J, Dand Replication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227
6 r# v7 E" r- ?2 F' hEmily Cousins and John Nicholas
2 u3 s$ g8 a ?3 iAnti-Viral Treatment and Cancer Control . . . . . . . . . . . . . . . . . . . . . 269
' I4 d: [0 L' [* S/ x1 G6 ?Wei-Liang Shih, Chi-Tai Fang and Pei-Jer Chen |
|